Treatment of the cyclo-P3 complexes [(triphos)MP3] [triphos = 1,1,1-tris(diphenylphosphinomethyl)ethane; M = Co (1), Rh (2)] with stoichiometric amounts of [M'(CO)5(thf)]n+ (n = 0, M' = Cr, Mo, W; n = 1, M' = Re) and [W(CO)4(PPh3)(thf)] yields the compounds [[(triphos)M](mu,eta 3:1-P3) [M'(CO)5]] [M = Co; M' = Cr (3a), Mo (3b), W (3c). M = Rh; M' = W (4)], [[(triphos)Co](mu,eta 3:1-P3)[Re(CO5)]]BF4.C7H8 (5) and [[(triphos)Rh](mu,eta 3:1-P3)[W(CO)4PPh3]].2CH2Cl2 (6). The X-ray structures of 5 and 6 have been determined. Crystal data: 5, monoclinic space group P2(1)/n, a = 14.754(2) A, b = 24.886(4) A, c = 15.182(2) A, beta = 103.38(1) degrees, Z = 4; 6, monoclinic space group P2(1)/n, a = 14.872(3) A, b = 27.317(6) A, c = 16.992(4) A, beta = 111.75(5) degrees, Z = 4. The effects of eta 1 coordination on the MP3 core are discussed by comparing the MP3 skeletons in the above structures with those of the previously characterized bis and tris end-on adducts of organometallic fragments of 1. Variable temperature NMR data for the compounds provide evidence for fluxional processes in solution that may be interpreted as [(triphos)M] rotation about its C3 axis and [M'(CO)5] or [M'(CO)4PPh3] scrambling over the P3 cycle. The activation parameters of the fragment scrambling process are determined.
No takes yet. Share an insight, caveat, or question.
Vaira et al. (2000) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: